Insiders · Profile

Monahan Joseph

Chief Scientific Officer at Aclaris Therapeutics. Filing since 2 Jun 2021. CIK 0001861790

Company

Date

Role

Action

Shares

Amount

Of holding

ACRS Aclaris Therapeutics, Inc.

23 Oct 2023

Chief Scientific Officer

Sold on a plan

6,000

$30.46K

4.4%

ACRS Aclaris Therapeutics, Inc.

21 Aug 2023

Chief Scientific Officer

Sold on a plan

6,000

$43.89K

4.2%

ACRS Aclaris Therapeutics, Inc.

20 Jun 2023

Chief Scientific Officer

Sold on a plan

6,000

$61.66K

4.1%

ACRS Aclaris Therapeutics, Inc.

3 Mar 2023

Chief Scientific Officer

Sold, plan not stated

16,037

$202.61K

9.8%

ACRS Aclaris Therapeutics, Inc.

2 Mar 2023

Chief Scientific Officer

Sold, plan not stated

14,800

$183.02K

8.9%

ACRS Aclaris Therapeutics, Inc.

15 Feb 2023

Chief Scientific Officer

Sold, plan not stated

5,000

$65.31K

5.2%

ACRS Aclaris Therapeutics, Inc.

15 Dec 2022

Chief Scientific Officer

Sold, plan not stated

5,000

$79.41K

4.9%

ACRS Aclaris Therapeutics, Inc.

17 Oct 2022

Chief Scientific Officer

Sold, plan not stated

5,000

$79.91K

4.7%

ACRS Aclaris Therapeutics, Inc.

18 Apr 2022

Chief Scientific Officer

Sold, plan not stated

30,000

$488.30K

22.0%

ACRS Aclaris Therapeutics, Inc.

10 Mar 2022

Chief Scientific Officer

Sold, plan not stated

27,165

$426.80K

16.6%

ACRS Aclaris Therapeutics, Inc.

9 Feb 2022

Chief Scientific Officer

Sold, plan not stated

383

$4.86K

0.4%

ACRS Aclaris Therapeutics, Inc.

2 Jun 2021

Chief Scientific Officer

Sold, plan not stated

21,790

$471.44K

20.3%

12 decisions on file.